Action to Cure Kidney Cancer
Search
Menu
Home
About Us
ACKC in the Press
ACKC Medical Director
ACKC Officers
Genesis of ACKC
Mission Statement
Photo Gallery
Position Paper
ACKC e-Newsletter
Volume 1 Issue 1
Volume 1 Issue 2
ACKC Slide Show
Kidney Cancer Info
What is Kidney Cancer?
Treatment Options
Latest Therapies
Interleukin-2
ASCO Reports
Report from ASCO 2009
Pazopanib versus Placebo
Prognostic Factors for Survival
Tivozanib versus Placebo
Pre-Surgical Study w/Avastin
Interleukin-21 and Nexavar
Report from ASCO 2008
Cediranib
Interleukin-21
Pazopanib
Sutent and Brain Metastases
Temsirolimus (Torisel)
TroVax
Report from ASCO 2007
Avastin and Interferon
Axitinib
Nexavar versus Placebo
Nexavar versus Interferon
Dose-Escalated Nexavar
Pazopanib
RAD001
Sutent versus Interferon
Sutent and Avastin
Sutent <-> Nexavar
Torisel versus Interferon
Report from ASCO 2006
Report from ASCO 2005
Kidney Disease and Kidney Cancer Survivors
Statistics
Incidence and Mortality
NCI Funding Leading Cancer Types
NCI Kidney Cancer Abstracts
NCI Kidney Cancer Budget
Per Capita Fed Research Funding
US Kidney Cancer Dist. Maps
AACR Conference
NCI Summit Meeting 2006
Assn Cancer Online Res. (ACOR)
Useful Links
Take Action
Military Aid for Kidney Cancer
Campaign 2006 (DoD)
Pfizer and Axitinib
Become an Advocate
Donate to ACKC
Congressional Committees
Look Up Your Congressman
Personal Stories
Stephen J Gould Essay
Personal Survivor Stories
Michael Kasper
Alan David
Ruth Love
Resources
Resources Home
Oncologist Index
Urologist Index
Projects
ACKC Funds Fellow at NIH
Paul Cairns Project
Kidney Cancer Researcher Wins DoD Grant
Maria F. Czyzyk-Krzeska Studies Genes in Kidney Cancer
Contact/Donate
Contact ACKC
Donate to ACKC
Events
Month
Week
Day
Table
